The BPHC Prevention Community of Practice (CoP) provides an opportunity for Federally Qualified Community Health Centers (FHQCs) in Philadelphia, Baltimore, and Washington, DC to learn from each other regarding increasing HIV testing, diagnosis, and prevention, including the provision of pre-exposure prophylaxis (PrEP). Health Resources and Services Administration’s (HRSA) Bureau of Primary Health Care (BPHC) and HIV/AIDS Bureau support this initiative to partner with Ending the HIV Epidemic-funded FQHCs in the MAAETC region.  

This program will review newly approved PrEP options, as well as those in late-stage clinical trial development.

PRESENTER: 

Caitlin Prather, PharmD, BCACP, AAHIVP, TTS

Clinical Pharmacy Specialist, Juniper and PRIDE Clinics

Residency Program Director, PGY2 Ambulatory Care

LEARNING OBJECTIVES: As a result of attending this program, participants should be able to:

1. Describe the newest options for biomedical HIV prevention
2. Review clinical trial findings of new PrEP formulations in development
3. Incorporate quality improvement measures to increase PrEP implementation at their site

CME and nursing credits will be available. 

Intended Audience

These trainings are designed for FQHC healthcare teams but are open to all health care professionals.

Contact